<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Prejano M</submitter><funding>Ciencia Básica y de Frontera</funding><funding>Estancias Posdoctorales por México</funding><funding>CONACyT</funding><funding>Università della Calabria</funding><funding>Dipartimento di Chimica e Tecnologie Chimiche</funding><pagination>e202400653</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11747580</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>26(1)</volume><pubmed_abstract>Quinoline represents a promising scaffold for developing potential drugs because of the wide range of biological and pharmacological activities that it exhibits. In the present study, quinoline derivatives obtained from CADMA-Chem docking protocol were investigated in the mean of molecular dynamics simulations as potential inhibitors of acetylcholinesterase enzyme. The examined species can be partitioned between neutral, dq815 (2,3 dihydroxyl-quinoline-4-carbaldehyde), dq829 (2,3 dihydroxyl-quinoline-8-carboxylic acid methane ester), dq1356 (3,4 dihydroxyl-quinoline-6-carbaldehyde), dq1368 (3,4 dihydroxyl-quinoline-8-carboxylic acid methane ester) and dq2357 (5,6 dihydroxyl-quinoline-8-carboxylic acid methane ester), and deprotonated, dq815_dep, dq829_dep, dq1356_dep and dq2357_dep. Twelve</pubmed_abstract><journal>Chemphyschem : a European journal of chemical physics and physical chemistry</journal><pubmed_title>Evaluating Quinolines: Molecular Dynamics Approach to Assess Their Potential as Acetylcholinesterase Inhibitors for Alzheimer's Disease.</pubmed_title><pmcid>PMC11747580</pmcid><funding_grant_id>CBF2023-2024-1141</funding_grant_id><pubmed_authors>Alcaro S</pubmed_authors><pubmed_authors>Prejano M</pubmed_authors><pubmed_authors>Felipe Hernandez-Ayala L</pubmed_authors><pubmed_authors>Galano A</pubmed_authors><pubmed_authors>Marino T</pubmed_authors><pubmed_authors>Romeo I</pubmed_authors><pubmed_authors>Gabriel Guzman-Lopez E</pubmed_authors></additional><is_claimable>false</is_claimable><name>Evaluating Quinolines: Molecular Dynamics Approach to Assess Their Potential as Acetylcholinesterase Inhibitors for Alzheimer's Disease.</name><description>Quinoline represents a promising scaffold for developing potential drugs because of the wide range of biological and pharmacological activities that it exhibits. In the present study, quinoline derivatives obtained from CADMA-Chem docking protocol were investigated in the mean of molecular dynamics simulations as potential inhibitors of acetylcholinesterase enzyme. The examined species can be partitioned between neutral, dq815 (2,3 dihydroxyl-quinoline-4-carbaldehyde), dq829 (2,3 dihydroxyl-quinoline-8-carboxylic acid methane ester), dq1356 (3,4 dihydroxyl-quinoline-6-carbaldehyde), dq1368 (3,4 dihydroxyl-quinoline-8-carboxylic acid methane ester) and dq2357 (5,6 dihydroxyl-quinoline-8-carboxylic acid methane ester), and deprotonated, dq815_dep, dq829_dep, dq1356_dep and dq2357_dep. Twelve</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jan</publication><modification>2026-05-02T14:32:45.42Z</modification><creation>2025-04-05T23:34:30.973Z</creation></dates><accession>S-EPMC11747580</accession><cross_references><pubmed>39301943</pubmed><doi>10.1002/cphc.202400653</doi></cross_references></HashMap>